Canopy Growth (CGC) Intangibles (2017 - 2026)
Canopy Growth (CGC) posted Intangibles of $173.1 million for Q1 2026, up 216.94% sequentially from $54.6 million in Q4 2025, and up 184.85% YoY from $60.8 million in Q1 2025.
Canopy Growth (CGC) Intangibles (2017 - 2026) Analysis & Trends
Canopy Growth has reported Intangibles for 10 years, with the latest figure at $173.1 million in Q1 2026.
- Quarterly Intangibles rose 184.85% year-over-year to $173.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $173.1 million (up 184.85% YoY) and the FY2026 annual result came in at $173.1 million, up 184.85% from the prior year.
- Intangibles rose to $173.1 million in Q1 2026 per CGC's latest filing, from $54.6 million in the prior quarter.
- Over five years, Intangibles peaked at $217.9 million in Q1 2022 and troughed at $38.2 million in Q2 2025.
- A 5-year average of $122.9 million and a median of $118.9 million in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2024 and 2026: Intangibles sank 62.27% in 2024, then surged 184.85% in 2026.
- Over 5 years, Intangibles stood at $207.5 million in 2022, then retreated by 28.95% to $147.4 million in 2023, then tumbled by 56.4% to $64.3 million in 2024, then declined by 15.03% to $54.6 million in 2025, then surged by 216.94% to $173.1 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $173.1 million, $54.6 million, and $59.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 1.12 Bn |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn | 212.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 212.47 Mn |
| Mar 31, 2026 | 173.11 Mn |
| Dec 31, 2025 | 54.62 Mn |
| Sep 30, 2025 | 58.96 Mn |
| Jun 30, 2025 | 38.21 Mn |
| Mar 31, 2025 | 60.77 Mn |
| Dec 31, 2024 | 64.28 Mn |
| Sep 30, 2024 | 148.22 Mn |
| Jun 30, 2024 | 51.38 Mn |
| Mar 31, 2024 | 77.22 Mn |
| Dec 31, 2023 | 147.41 Mn |
| Sep 30, 2023 | 110.97 Mn |
| Jun 30, 2023 | 136.19 Mn |
| Mar 31, 2023 | 118.91 Mn |
| Dec 31, 2022 | 207.47 Mn |
| Sep 30, 2022 | 210.17 Mn |
| Jun 30, 2022 | 214.09 Mn |
| Mar 31, 2022 | 217.94 Mn |
| Dec 31, 2021 | 177.69 Mn |
| Sep 30, 2021 | 184.56 Mn |